Vendor, Houston, TX
Avance Biosciences Inc.
UEI CCR1QNNDEEV3, CAGE 8MXK2
1 award and -$50 obligated between August 27, 2026 and August 27, 2026, 0% under full and open competition, against 1.0 offers on average where reported.
How it wins
Awards by competition, set-aside and type.
| Not Competed Under SAP | 1 |
| Purchase Order | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 75N93021P00504Purchase Order, August 27, 2026, Not Competed Under SAP, 1 offers | National Institutes of Health NiaidNational Institutes of Health | To Administratively De-Obligate Unexpended and Expiring Fiscal Year 2021 Funding in Accordance with 31 U.S.C. Section 1552 (A), in PreparatiNAICS 541380, PSC B504 | -$50 |
- Places of performance
- Texas
- Product and service codes
- B504 Chemical/Biological Studies and Analysis
- Transactions
- 1 across 1 awards